CClinicalTrials.gg
RecruitingNCT07019116Updated Feb 20, 2026

Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care

An interventional study of Standard gatekeeping and AI algorithm in Primary Care and Primary Care Patients With Chronic Conditions, sponsored by Hospital de Clinicas de Porto Alegre. Recruiting at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Nov 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
934
Allocation
Randomized
Sex
All
01

Study summary

In Rio Grande do Sul, Brazil, the demand for specialty care referrals has increased sharply with the adoption of the electronic regulatory system, especially in rural areas. In 2023 alone, over 79,000 referrals were submitted monthly, totaling 1.7 million annual gatekeeping decisions. Due to workforce limitations, nearly 70% of referrals are authorized automatically, often without clinical validation. This leads to delays for high-risk patients, unnecessary specialist visits, and a growing backlog, currently over 172,000 pending referrals. To address this, an AI algorithm was developed to triage referrals based on urgency and appropriateness.

The investigators propose a prospective controlled study with randomized implementation of the AI tool across selected specialty queues in the electronic referral system. The population will consist of referrals from specialties waitlists from municipalities in Rio Grande do Sul. Specialties to be included will be selected by the State Health Department prospectively according to gatekeeping needs. The intervention will be an AI-based triage algorithm. The control will be a standard gatekeeping process. The primary outcome is the proportion of referrals with a final decision (authorized or redirected to primary care) within six months; secondary outcomes include time to decision and appointment, system-level performance metrics. Referrals will be randomly assigned to algorithmic or human gatekeeping with a 1:1 ratio. The algorithm classifies referrals into two groups: not authorized (pending more data or teleconsultation), authorized. Authorization cases are further divided into routine and high-risk referrals to help the manage demand. Each AI prediction provides a probability from 0 to 1 of authorization (or deferring). The implementation threshold is set at 0.8; cases below this level will be classified as low confidence for decision and will not be included. According to the State Health Department's decisions, several referral lines are expected to be selected for the intervention. A sample size 934 (467 per arm) for each included specialty was calculated to detect a 1.2 relative risk for the primary outcome with 90% power and 5% significance.

02

Conditions studied

  • Primary Care
  • Primary Care Patients With Chronic Conditions
03

In context

Lead sponsor

Hospital de Clinicas de Porto Alegre is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All referrals from a given specialty (waitlist) will be eligible.
  • Specialties will be selected following Rio Grande do Sul Health Department priorities.

Exclusion criteria

Exclusion Criteria:

  • Referrals that the AI algorithm can not evaluate. These include referrals with attachments (further information in image or PDF files) and referrals with previous rounds of discussion.
  • Referrals in which the algorithm has low confidence in the decision (i.e., informed data lead to a decision with a probability below 80%) will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
934 participants (estimated)

Study arms

  • Active comparator
    Standard gatekeeping process

    In standard gatekeeping, the current process will be used without interventions.

    Other: Standard gatekeeping · Other: Subsequent interactions between primary care and regulation system

  • Experimental
    Artificial Intelligence for Gatekeeping

    An AI algorithm will perform the first evaluation (triaging) of the referral.

    Other: AI algorithm · Other: Subsequent interactions between primary care and regulation system

Interventions

  • OtherStandard gatekeeping

    Human evaluators (mostly physicians) review referrals and determine, based on established protocols, whether they should be authorized.

  • OtherAI algorithm

    An AI algorithm was developed to perform the first evaluation (triaging) of the referrals inserted in the electronic referral system from the Rio Grande do Sul Health Department.

  • OtherSubsequent interactions between primary care and regulation system

    After the first evaluation of a referral, several subsequent rounds of interaction between gatekeepers and primary care physicians can be conducted to further detail patient needs and urgency.

06

What researchers measure

Primary outcomes

  1. Referrals with final decision

    The proportion of referrals with a final decision includes those authorized for specialist care and those redirected to primary care without an in-person specialist consultation.

    Time frame: 6 months

Secondary outcomes

  1. Time to final decision

    Time to final decision (authorization or deferral) for the referral.

    Time frame: 6 months

  2. Time to consult in high-risk patients

    Time to specialist appointment for high-priority (red/orange) cases.

    Time frame: 6 months

  3. Use of remote consultations

    Rio Grande do Sul has a provider-to-provider consultation service. The proportion of referrals that used this service will be assessed.

    Time frame: 6 months

  4. Waitlist size over time

    The overall size of the referral waitlist will be assessed before and after the implementation of the algorithm.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Central de Regulação Ambulatorial
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Final data responsibility lies with the Rio Grande do Sul State Health Department, and the data are classified as high-risk health data under the Brazilian General Data Protection Law.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07019116
Lead sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Rio Grande do Sul State Health Department - SES/RS
Responsible party
Sponsor
First posted
Jun 13, 2025
Start date
Nov 15, 2025
Primary completion
Dec 2028 (estimated)
Completion
Dec 2029 (estimated)
Last update
Feb 20, 2026

Study contacts

Dimitris V Rados, Ph.D.
Contact
drados@hcpa.edu.br
+555133082092
Natan Katz, Ph.D.
Contact
nkatz@hcpa.edu.br
+555133082092
Dimitris V. Rados, Ph.D.
principal investigator · TelessaúdeRS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion